BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/100/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 01:45:47 2024-07-04 pm EDT | ||
| 0.24 EUR | +13.74% |
|
| Current month | -11.11% | ||
| 1 month | +37.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-04 | 0.24 | +13.74% |
| 24-07-03 | 0.211 | +7.65% |
| 24-07-02 | 0.196 | -1.51% |
| 24-07-01 | 0.199 | -26.30% |
| 24-06-28 | 0.27 | -6.90% |
Delayed Quote Deutsche Boerse AG
Last update July 04, 2024 at 01:45 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM9VDS |
| ISIN | DE000VM9VDS1 |
| Date issued | 2024-02-06 |
| Strike | 100 $ |
| Maturity | 2024-09-20 (78 Days) |
| Parity | 10 : 1 |
| Emission price | 0.37 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.69 € |
|---|---|
| Lowest since issue | 0.131 € |
| Spread | 0.03 € |
| Spread % | 11.11% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.13
USD
Spread / Average Target
+5.54%
- Stock Market
- Warrants
- Warrant
